soul trial oral semaglutide cardiovascular outcomes results Reduces Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary From the Randomized Abstract 4367751: Cardiovascular Outcomes of

#GLP1 #WeightLoss #Obesity #Cosmetics | Sohini Das GLP-1 drugs misuse risks with cheaper generics Doctors caution against cosmetic misuse of GLP-1 drugs as cheaper generics boost access, raising risks of unsupervised use and short-term weight-loss trends

[DOI] [PubMed] [Google Scholar] 17.Keller J, Ringseis R, Koc A, Lukas I, Kluge H, Eder K

Examined for involvement in angiogenesis and vascular function in experimental systems

After graduating as a doctor, she worked within the West Midlands in Urology, Respiratory Medicine, Infectious Disease, and Psychiatry before transitioning into a full-time medical communications role